Skip to main content
. 2020 Jun 30;9(6):2843–2848. doi: 10.4103/jfmpc.jfmpc_265_20

Table 2.

Staging and Treatment of the Retinoblastoma patients

Characteristic Number of patient (%)
Clinical staging
Intraocular disease (Stage 1) 14 (58.3%)
Stage B 1
Stage C 2
Stage D 6
Stage E 5
Optic nerve involvement (stage II) 8 (33.3%)
Lymph node involvement (stage III) 1 (4.1%)
Intracranial spread (stage IV) 1 (4.1%)
Treatment
Surgery
Enucleation 21 (87.5%)
Laser therapy 2 (8.3%)
EBRT 2
Chemotherapy
6 cycles 14
2-4 cycles 7
Adjuvant chemotherapy 3